Scientists look to outliers in quest for cures

09/19/2013 | Reuters

Advances in genome sequencing technology are allowing researchers to study why some patients respond well to treatments that fail in others with the same disease. The research could lead to new uses for existing and abandoned compounds, researchers say. Projects are planned or underway at the National Cancer Institute, Memorial Sloan-Kettering Cancer Center, MD Anderson Cancer Center and Dana-Farber Cancer Institute, among others.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Clinical Operations
Meridian Health Plan
Detroit, MI
Sr. Director, Regulatory Compliance Intelligence and Outreach
Johnson & Johnson
New Brunswick, NJ
RN Care Manager
MJHS
Brooklyn, NY
Director of Utilization Management
Meridian Health Plan
Chicago, IL
Senior Manager, Healthcare Reform
Avalere Health
Washington, DC